A new study published in September has reinforced how, for people with IBS who have been taught the low FODMAP diet, uncontrolled digestive symptoms and psychological distress can be linked to disordered eating behaviours. It can help us think about how patients are...
The Financial Infrastructure Behind Healthcare Innovation
Healthcare is changing faster than I have ever seen it change, and the revenue cycle has to keep pace. We are talking about AI, new treatments, new technology, new specialties and entirely new ways of delivering care. All of that is exciting, and much of it has the...
When the Model Is Confident and the Patient Is Not
It is 2:07 a.m. in the emergency department. The waiting room is thin. The hallway is not. A middle-aged man looks pale. His vitals sit in the green band. A clinical decision support tile on the chart says low risk with a high confidence score. His wife keeps saying...
Weekly News Roundup | 28 September 2026
Life science news 28 September 2026: four US drug approvals, three UK developments and two global R&D deals. The FDA approved Atebrioz, the third treatment for fibrodysplasia ossificans progressiva, and AbbVie’s Parkinson’s drug Juvmo. The MHRA approved...
Surgical Site Infections Can Consume Up to 75 Staff Hours
Surgical site infections can consume up to 75 staff hours and displace three operations, research finds A single surgical site infection (SSI) can consume an estimated 45 to 75 additional hours of healthcare staff time and create downstream demands equivalent to the...
Amylin Analogues Explained: The Next Obesity Drug Battleground
Amylin analogues have become one of the most active areas of obesity drug development. Novo Nordisk, Eli Lilly, Roche, Pfizer, AbbVie and AstraZeneca all hold clinical programmes built on the hormone amylin. The most advanced obesity candidate in the class, Novo...
Weekly News Roundup | 07 September 2026
Life science news 7 September 2026: two US approvals, a UK suspension, a Phase 3 failure and four global deals. PharmaEssentia won FDA approval for Besremi in essential thrombocythemia, a label expansion for the interferon therapy. The MHRA suspended Avacopan Vifor...
GLP-1 Indications: The 2026 Regulatory Status Map
The list of approved GLP-1 indications now reaches well beyond weight loss and glycaemic control. Regulators in three major markets have licensed the class across cardiology, nephrology and hepatology. Other conditions carry positive phase 3 data but no licence at...
AI in MedTech: Accelerating the Product Development Lifecycle
Developing a new medical device is a lengthy, complex process that typically takes between three to seven years from conception to market [1]. For MedTech companies operating within highly regulated environments where compliance and patient safety are paramount,...
Midlife Metabolic Change: How Behaviour, Nutrition and Stress Shape Health
Midlife marks one of the most significant physiological transitions in the human lifespan. For many individuals, particularly those navigating perimenopause and menopause, metabolic stability becomes harder to maintain, appetite signals shift, energy becomes less...
UK Animal Testing Deadline: What December Actually Requires
The UK animal testing deadline that matters most falls at the end of December. By then, regulatory testing on animals for skin irritation, eye irritation and skin sensitisation is meant to stop. It is the largest of a cluster of targets the Replacing Animals in...
Weekly News Roundup | 31 August 2026
Life science news 31 August 2026: three US approvals, two UK device safety alerts and two licensing deals. Revolution Medicines won approval for a broad RAS-targeted pancreatic cancer drug. AstraZeneca and Ionis presented the full data behind a closely watched heart...
Leverage Trauma-Informed Care to Enhance Adherence to Safety Interventions
Patient trauma can have a significant impact on the ways in which patients interact with the healthcare environment and with its staff. Many patient behaviors can stem from trauma, including lack of adherence to care plans. In the context of patient safety,...
Robotic Gastrectomy Outperforms Laparoscopic Surgery in Japanese Study
Robotic gastrectomy delivers measurably better perioperative outcomes than conventional laparoscopic surgery for gastric cancer, according to a nationwide analysis of Japanese surgical practice covering more than 22,000 patients. Gastric cancer is the fifth most...
Weekly News Roundup | 24 August 2026
Life science news 24 August 2026: the FDA clears Regeneron’s Pasatru for an ultra-rare bone disorder and grants Ultragenyx the first gene therapy for glycogen storage disease type Ia, authorises the first standalone robotic blood-draw device, and the MHRA opens a...
The Ketogenic Diet: Why Long-Term Safety Deserves Greater Scrutiny
The ketogenic diet has transitioned from a highly specialized therapeutic intervention to a widely promoted dietary strategy for weight loss, metabolic health, inflammation, and, in some circles, cancer prevention or treatment. Its popularity has outpaced the strength...
Physical Activity and Dementia: The Evidence Base Is Uneven
The link between physical activity and dementia depends on where that activity happens, according to a meta analysis of 74 studies covering more than four million adults. Leisure time exercise was associated with a lower risk of dementia, while activity undertaken at...
Australia Marks 40 years of Daffodil Day on Thursday 20 August
Cancer Council calls on Australians to help fund the next 40 years of breakthroughs One of Australia's most iconic and enduring fundraising campaigns, Daffodil Day, will return on Thursday 20 August 2026, marking 40 years of Australians coming together to support...







